Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04601857 |
|---|---|
| Brief Title: | Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma |
| First Submitted : | October 15, 2020 |
| First Submitted that Met QC Criteria : | October 22, 2020 |
| First Posted : | October 26, 2020 |
| Last Update Submitted that Met QC Criteria : | April 11, 2024 |
| Last Update Posted : | April 12, 2024 |